| Literature DB >> 26019517 |
Na Yu1, Lu He1, Na Liu2, Yong Wang1, Hongbo Xu1, Dandan Liu1.
Abstract
Endophytic fungus BS002 was isolated and characterized from Sophora flavescens by plate method, which has broad antimicrobial activity. Isolation and trace of a new bioactive compound from the fungus' culture extracts with the method of column chromatography and TLC biological autoradiography was conducted. Finally, it was identified as 6,7-(2'E) dibutenyl-5,8-dihydroxy-(Z)-cyclooct-2-ene-1,4-dione by nuclear magnetic resonance, infrared and liquid chromatography-mass spectrometry. The compound presented strong antifungal activities for example: Botryosphaeria berengriana f.sp. piricola, Physalospora piricola, Cladosporium cucumerinum Ell. Arthur., Fusarium oxysporum f.sp. cucumerinum, Fusarium moniliforme. The inhibition to Physalospora piricola was the strongest with an antibacterial diameter of 45 mm. This paper is the first report of the antimicrobial activity of endophytic fungi BS002 that was the secondary metabolites extracted from the seeds of Sophora flavescens. The results provide a broad foreground for biopharmaceuticals and biopesticide.Entities:
Keywords: Sophora flavescens; TLC biological autoradiography; antimicrobial substance; endophytic fungi; isolation; structure analysis
Year: 2014 PMID: 26019517 PMCID: PMC4434118 DOI: 10.1080/13102818.2014.911618
Source DB: PubMed Journal: Biotechnol Biotechnol Equip ISSN: 1310-2818 Impact factor: 1.632
Figure 1. Colony of endophytic fungus BS002.
Figure 2. Fruiting bodies morphology of endophytic fungus BS002 (400×).
Antimicrobial activity of the endophytic fungus BS002.
| Pathogenic fungi | Antibacterial diameter (mm) | Pathogenic fungi | Antibacterial diameter (mm) |
|---|---|---|---|
| 14 | 21 | ||
| 8 | 13 | ||
| 13 | 8 | ||
| 17 | 12 | ||
| 10 | 27 | ||
| 14 | 8 | ||
| 7 | 11 | ||
| 9 | 10 | ||
| 8 | 12 | ||
| 45 | 7 | ||
| 8 | 8 | ||
| 9 | 13 |
Note: Different small and capital letters mean significant differences at 0.05 and 0.01 levels, respectively.
Figure 3. The H1-H1-COSY and the key HMBC of the new compound.
Data of the 13C-NMR (125 MHz) and 1H-NMR (500 MHz) (MeOD, δ in ppm).
| Position | C | H |
|---|---|---|
| 1 | 205.9 | |
| 2 | 124.6 | 6.09(1H, s) |
| 3 | 124.6 | 6.09(1H, s) |
| 4 | 205.9 | |
| 5 | 80.5 | 4.23(1H, br s) |
| 6 | 76.1 | 4.82(1H, br s) |
| 7 | 76.1 | 4.82(1H, br s) |
| 8 | 80.5 | 4.23(1H, br s) |
| 1′ | 170.9 | |
| 2′ | 124.5 | 6.43(1H, d) |
| 3′ | 143.5 | 6.81(1H, dq, |
| 4′ | 18.9 | 1.90(3H, d, |
| 1″ | 170.9 | |
| 2″ | 124.5 | 6.81(1H, dq, |
| 3″ | 143.5 | 6.81(1H, m) |
| 4″ | 18.9 | 1.90(3H, d, |
Note: All spectra were recorded on AV500, in MeOD, δ in ppm.